SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Titan Biotech informs about newspaper publication

02 Jul 2022 Evaluate

Titan Biotech has informed about Newspaper Advertisement copies for the notice to Shareholders For Unclaimed Dividend whose dividend(s) are unclaimed for 7 consecutive years and whose shares are liable to be transferred to IEPF.

The above information is a part of company’s filings submitted to BSE.

Titan Bio-Tech Share Price

434.10 5.65 (1.32%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2709.30
BASF India 3492.00
Tata Chemicals 729.50
Pidilite Inds. 1579.50
Deepak Nitrite 1645.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: